azmkwells……Hello from me as well. I assume that you are receiving gemcitabine and cisplatin, first line treatment for this cancer. Obtaining a second opinion has become standard of care, something already your are contemplating. I also wanted to mention that USC, Los Angeles, has a robust biiary department and treats a high volume of Cholangiocarcinoma patients.
On another note: nearly 30% of intrahepatic cholangiocarcinoma patients harbor the ID-L1 tumor gene, which may respond to immunotherapy treatments. You would want to investigate this further.
http://www.cancer.gov/research/areas/treatment/immunotherapy-using-immune-system
Hugs,
Marion